ArticleGene2021

Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.

Masaya Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.